New evidence that virus may cause chronic fatigue
A well-respected team of scientists released long-awaited new evidence Monday that a virus may be playing a role in chronic fatigue syndrome.
The researchers, from the National Institutes of Health, the Food and Drug Administration and Harvard Medical School, analyzed blood samples that had been collected 15 years ago from 37 patients with chronic fatigue syndrome. Most of the subjects--32, or 86.5 percent--tested positive for a virus known as a murine leukemia virus-related virus, the researchers found. In contrast, tests on 44 healthy blood donors detected evidence of the virus in only three of the subjects, or 6.8 percent.
While providing new evidence that a virus may play a role in the mysterious condition, the researchers said the findings, published in the Proceedings of the National Academy of Sciences, are no where near proving the virus causes the syndrome.
But the findings are being hailed by advocates for chronic fatigue syndrome patients, such as the CFID Association of America. The head of that group, Kim McCleary, says the findings are a potentially important step toward finding the cause of the condition and possibly developing treatments, as well as dispelling the notion that the condition is really psychological.
Between 1 million to 4 million Americans are believed to suffer from the syndrome, which causes prolonged and severe fatigue, body aches and other symptoms. The cause has long been a mystery. Over the years, many viruses have been linked to the syndrome, only to end up being a dead end.
But in 2009, Judy Mikovits and colleagues at the Whittemore Peterson Institute in Reno, Nevada, published a paper in the well-respected journal Science. That paper reported that many syndrome patients appeared to be infected with a little-known virus called the xenotrophic murine leukemia virus-related virus, or XMRV. XMRV is a so-called retrovirus, which is the same type of virus as the AIDS virus. XMRV had also been found in some prostate cancer patients.
But four other groups, including a team at the federal Centers for Disease Control and Prevention in Atlanta, subsequently failed to duplicate the findings in other patients, raising deep suspicions that this was yet another wild goose chase.
The new findings will probably revive interest in the virus. The virus detected in the new study does not appear to be exactly the same one the Reno group found, but it is closely related. In addition to detecting evidence of the microbe in an overwhelming majority of the stored blood samples, the researchers found evidence of virus in fresh blood samples from seven of eight of the patients, indicating that the infection persists. Harvey Alter of the NIH, who helped conduct the study, says there also were indications the virus had evolved slightly over time, which is what would be expected from a retrovirus.
The paper's publication was delayed because of questions about whether the findings could have been the result of laboratory contamination. That prompted the researchers to conduct a series of additional tests to try to rule that out, and rumors that the research was being suppressed. But in an editorial accompanying the paper, the journal's editor said the additional studies were important to validate the findings.
Some researchers are continuing to question whether the scientists had completely ruled out contamination. And almost everyone is urging great caution in rushing to any conclusions. But the researchers say they are confident they ruled out laboratory contamination. They're not sure why they found evidence of the virus in syndrome patients while others failed. But they speculated there could be a variety of explanations, including that they tested a better-defined group of patients or perhaps that the virus is only found in patients in some geographic areas.
In a commentary accompanying the study, Andrew Mason of the University of Alberta in Canada and colleagues argued that one of the next steps might be to try testing antiviral drugs on chronic fatigue patients in a carefully designed study.
Not everyone thinks there's enough evidence for that yet, given that antiviral drugs can have side effects. But Mikovits and her colleagues at the Reno clinic who made the original discovery say they are hoping a drug company will step forward to fund that kind of study.
Meantime, researchers from various groups are working together to try to develop standardized ways to test patients for the virus to see if they can further validate the connection between the virus and the syndrome. The FDA and CDC are very interested in pursuing this, in no small part because if the virus does cause the condition then blood donors may need to be screened for it to protect transfusion recipients.
For more information about this from the CDC cick here.
August 23, 2010; 3:00 PM ET
Categories: Chronic Conditions , Infectious Disease , Women's Health
Save & Share: Previous: Food safety appointee has work cut out for her
Next: Tweeting about your diet
Posted by: newsboy3 | August 23, 2010 3:13 PM | Report abuse
Posted by: maddymappo | August 23, 2010 4:01 PM | Report abuse
Posted by: JohnStClair | August 23, 2010 4:24 PM | Report abuse
Posted by: gannon_dick | August 23, 2010 4:27 PM | Report abuse
Posted by: crashprevention | August 23, 2010 4:27 PM | Report abuse
Posted by: gannon_dick | August 23, 2010 4:43 PM | Report abuse
Posted by: oerganix | August 23, 2010 7:03 PM | Report abuse
Posted by: greeenmtns | August 23, 2010 7:33 PM | Report abuse
Posted by: ajlerner1 | August 23, 2010 7:43 PM | Report abuse
Posted by: JohnStClair | August 23, 2010 7:58 PM | Report abuse
Posted by: windhill1 | August 23, 2010 8:17 PM | Report abuse
Posted by: windhill1 | August 23, 2010 8:18 PM | Report abuse
Posted by: Virginian_Ace | August 23, 2010 9:06 PM | Report abuse
Posted by: Blurgle | August 23, 2010 9:13 PM | Report abuse
Posted by: scrivener50 | August 24, 2010 1:08 PM | Report abuse
Posted by: karen60 | August 25, 2010 11:16 AM | Report abuse
Posted by: KAL6196 | August 25, 2010 12:36 PM | Report abuse
The comments to this entry are closed.